Topotecan/docetaxel combination (IV)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Topotecan/docetaxel combination (IV), covering 2019-06-24 to 2019-06-24. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer [Phase 2]